Clinical Study
C-Reactive Protein Levels in the Brugada Syndrome
Table 1
Baseline characteristics of asymptomatic and symptomatic BrS patients.
| | Asymptomatic () | Symptomatic () | value | 95% CI | | Univariate analysis | Multivariate analysis |
| | Age (years) | | | .001 | .009 | 1.56–22.08 | | Male | 32 (94%) | 17 (85%) | ns | — | | | Hypertension | 3 (9%) | 5 (25%) | ns | — | | | Hypercholesterolemia | 6 (18%) | 3 (15%) | ns | — | | | Smokers | 6 (18%) | 2 (10%) | ns | — | | | Diabetes | 0 | 1 (5%) | ns | — | | | Statin | 1 (3%) | 2 (10%) | ns | — | | | Aspirin | 0 | 1 (5%) | ns | — | | | First-degree AV block | 4 (12%) | 5 (25%) | ns | — | | | QRS > 120 ms | 10 (29%) | 3 (15%) | ns | — | | | Type 1 ECG pattern | 19 (56%) | 14 (70%) | ns | — | | | CRP ≥ 2 mg/L | 11 (32%) | 15 (75%) | .003 | .018 | 1.32–19.31 |
|
|
